Trial · NCT02527200
Registered outcomes106
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 106
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Body Mass Index (BMI) Standard Deviation Score (SDS) From Baseline to 16 Weeks | Week 0, Week 16 | Change in BMI SDS from baseline to week 16 is presented. BMI SDS also called Z-scores, was calculated using the following formula: Z=\[(y / M)\^L - 1\] / S\*L; where L, M and S are median (M), Box-cox power (L) and variation coefficient (S) of children/adolescents', y= individual BMI. BMI provided for each sex and age. For each participant, a standard deviation score Z (SDS) was calculated based on age and sex referring to the values L, M and S. Possible values range from -3 to +3, a negative score being beneficial. |
| Primary | Change in Body Mass Index (BMI) Standard Deviation Score (SDS) From Baseline to 52 Weeks | Week 0, Week 52 | Change in BMI SDS from baseline to week 52 is presented. BMI SDS also called Z-scores, was calculated using the following formula: Z=\[(y / M)\^L - 1\] / S\*L; where L, M and S are median (M), Box-cox power (L) and variation coefficient (S) of children/adolescents', y= individual BMI. BMI provided for each sex and age. For each participant, a standard deviation score Z (SDS) was calculated based on age and sex referring to the values L, M and S. Possible values range from -3 to +3, a negative score being beneficial. |
| Secondary | Percentage of Participants Achieving ≥ 5% Reduction in Baseline BMI at Week 16 | At week 16 | Percentage of participants achieving more than or equal to (≥) 5% reduction in their baseline (week 0) BMI at week 16 is presented. In below table, 'Yes' infers percentage of participants who achieved ≥ 5% reduction in their baseline (week 0) BMI at week 16 and 'No' infers percentage of participants who did not achieve ≥ 5% reduction in their baseline (week 0) BMI at week 16. |
| Secondary | Percentage of Participants Achieving ≥ 5% Reduction in Baseline BMI at Week 52 | At week 52 | Percentage of participants achieving more than or equal to (≥) 5% reduction in their baseline (week 0) BMI at week 52 is presented. In below table, 'Yes' infers percentage of participants who achieved ≥ 5% reduction in their baseline (week 0) BMI at week 52 and 'No' infers percentage of participants who did not achieve ≥ 5% reduction in their baseline (week 0) BMI at week 52. |
| Secondary | Percentage of Participants Achieving ≥ 10% Reduction in Baseline BMI at Week 16 | At week 16 | Percentage of participants achieving more than or equal to (≥) 10% reduction in their baseline (week 0) BMI at week 16 is presented. In below table, 'Yes' infers percentage of participants who achieved ≥ 10% reduction in their baseline (week 0) BMI at week 16 and 'No' infers percentage of participants who did not achieve ≥ 10% reduction in their baseline (week 0) BMI at week 16. |
| Secondary | Percentage of Participants Achieving ≥ 10% Reduction in Baseline BMI at Week 52 | At week 52 | Percentage of participants achieving more than or equal to (≥) 10% reduction in their baseline (week 0) BMI at week 52 is presented. In below table, 'Yes' infers percentage of participants who achieved ≥ 10% reduction in their baseline (week 0) BMI at week 52 and 'No' infers percentage of participants who did not achieve ≥ 10% reduction in their baseline (week 0) BMI at week 52. |
| Secondary | Percentage of Participants With no Increase in BMI SDS at Week 16 | At week 16 | Percentage of participants with no increase in BMI SDS at week 16 is presented. In below table, 'Yes' infers percentage of participants with no increase in BMI SDS at week 16 and 'No' infers percentage of participants with increase in BMI SDS at week 16. |
| Secondary | Percentage of Participants With no Increase in BMI SDS at Week 52 | At week 52 | Percentage of participants with no increase in BMI SDS at week 52 is presented. In below table, 'Yes' infers percentage of participants with no increase in BMI SDS at week 52 and 'No' infers percentage of participants with increase in BMI SDS at week 52. |
| Secondary | Change in BMI From Baseline at Week 16 | Week 0, week 16 | Change in body mass index (BMI) from baseline to week 16 is presented. |
| Secondary | Change in BMI From Baseline at Week 52 | Week 0, week 52 | Change in body mass index (BMI) from baseline to week 52 is presented. |
| Secondary | Change in Body Weight (Kilogram (kg)) From Baseline at Week 16 | Week 0, week 16 | Change in body weight (kg) from baseline to week 16 is presented. |
| Secondary | Change in Body Weight (kg) From Baseline at Week 52 | Week 0, week 52 | Change in body weight (kg) from baseline to week 52 is presented. |
| Secondary | Change in Body Weight (Pounds (lb)) From Baseline at Week 16 | Week 0, week 16 | Change in body weight (lb) from baseline to week 16 is presented. |
| Secondary | Change in Body Weight (lb) From Baseline at Week 52 | Week 0, week 52 | Change in body weight (lb) from baseline to week 52 is presented. |
| Secondary | Change in Body Weight (Percentage [%]) From Baseline at Week 16 | Week 0, week 16 | Change in body weight (%) from baseline to week 16 is presented. |
| Secondary | Change in Body Weight (%) From Baseline at Week 52 | Week 0, week 52 | Change in body weight (%) from baseline to week 52 is presented. |
| Secondary | Change in Waist Circumference From Baseline at Week 16 | Week 0, week 16 | Change in waist circumference from baseline to week 16 is presented. |
| Secondary | Change in Waist Circumference From Baseline at Week 52 | Week 0, week 52 | Change in waist circumference from baseline to week 52 is presented. |
| Secondary | Change in Waist-to-hip Circumference Ratio From Baseline at Week 16 | Week 0, week 16 | Change in waist-to-hip circumference ratio from baseline to week 16 is presented. |
| Secondary | Change in Waist-to-hip Circumference Ratio From Baseline at Week 52 | Week 0, week 52 | Change in waist-to-hip circumference ratio from baseline to week 52 is presented. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02527200/registered